ESSA Pharma Inc.
Related Filers (53)
- EVENTIDE ASSET MANAGEMENT, LLC (11)
- BB BIOTECH AG (11)
- Virsik Peter (9)
- BIOTECHNOLOGY VALUE FUND L P (8)
- BERGER FRANKLIN M (8)
- Soleus Capital, LLC (7)
- Clarus Lifesciences III, L.P. (6)
- BIOTECH GROWTH N V (6)
- Parkinson David Ross (6)
- Glickman Richard M (5)
- Omega Fund IV, L.P. (5)
- Requadt Scott (5)
- Wood David S. (5)
- Flynn James E (4)
- Thorell Marella (4)
- Sollis Gary (4)
- ZWEIFACH SANFORD S (4)
- Martin John Alexander (4)
- RTW INVESTMENTS, LP (4)
- Brettman Ari David (3)
- DRIEHAUS CAPITAL MANAGEMENT LLC (3)
- Vivo Capital IX, LLC (3)
- Cesano Alessandra (3)
- PFM Health Sciences, LP (3)
- Andersen Raymond John (2)
- Sadar Marianne D. (2)
- MARXE AUSTIN W & GREENHOUSE DAVID M (2)
- ORBIMED ADVISORS LLC (2)
- PFIZER INC (2)
- JANUS HENDERSON GROUP PLC (2)
- Avidity Partners Management LP (2)
- Gagnon Robert E. (2)
- Rieder Robert William (1)
- AWM Investment Company, Inc. (1)
- SCHWARZMAN STEPHEN A (1)
- Blackstone Clarus III L.L.C. (1)
- Clarus Ventures III GP, L.P. (1)
- Blackstone Group Inc (1)
- Blackstone Holdings I/II GP L.L.C. (1)
- Blackstone Group Management L.L.C. (1)
- Blackstone Holdings II L.P. (1)
- BVF PARTNERS L P/IL (1)
- BVF GP HOLDINGS LLC (1)
- BVF Partners OS Ltd. (1)
- BVF I GP LLC (1)
- BIOTECHNOLOGY VALUE FUND II LP (1)
- LAMPERT MARK N (1)
- BVF INC/IL (1)
- BVF II GP LLC (1)
- Biotechnology Value Trading Fund OS LP (1)
- Kantoff Philip W. (1)
- Merendino Lauren (1)
- MORGAN STANLEY (1)
- Show More ...
Financials (14)
10-Q
Tuesday, 2/13/2024
Quarterly Report for period ending 2023-12-31
10-K
Tuesday, 12/12/2023
Annual Report for period ending 2023-09-30
10-Q
Tuesday, 8/8/2023
Quarterly Report for period ending 2023-06-30
10-Q
Tuesday, 5/9/2023
Quarterly Report for period ending 2023-03-31
10-Q
Tuesday, 2/7/2023
Quarterly Report for period ending 2022-12-31
10-K
Tuesday, 12/13/2022
Annual Report for period ending 2022-09-30
10-Q
Thursday, 8/4/2022
Quarterly Report for period ending 2022-06-30
10-Q
Tuesday, 5/10/2022
Quarterly Report for period ending 2022-03-31
10-Q
Thursday, 2/3/2022
Quarterly Report for period ending 2021-12-31
10-K
Thursday, 11/18/2021
Annual Report for period ending 2021-09-30
10-Q
Monday, 8/16/2021
Quarterly Report for period ending 2021-06-30
10-Q
Thursday, 5/6/2021
Quarterly Report for period ending 2021-03-31
10-Q
Thursday, 2/11/2021
Quarterly Report for period ending 2020-12-31
10-K
Tuesday, 12/15/2020
Annual Report for period ending 2020-09-30
News (29)
8-K
Tuesday, 2/13/2024
Current report filing
8-K
Monday, 1/29/2024
Current report filing
8-K
Tuesday, 12/12/2023
Current report filing
8-K
Monday, 11/6/2023
Current report filing
8-K
Friday, 10/27/2023
Current report filing
8-K
Monday, 10/23/2023
Current report filing
8-K
Monday, 9/18/2023
Current report filing
8-K
Monday, 9/18/2023
Current report filing
8-K
Tuesday, 8/8/2023
Current report filing
8-K
Tuesday, 6/6/2023
Current report filing
8-K
Tuesday, 5/9/2023
Current report filing
8-K
Wednesday, 4/12/2023
Current report filing
8-K
Friday, 3/10/2023
Current report filing
8-K
Tuesday, 2/7/2023
Current report filing
8-K
Tuesday, 12/13/2022
Current report filing
8-K
Monday, 10/31/2022
Current report filing
8-K
Wednesday, 10/26/2022
Current report filing
8-K
Tuesday, 9/13/2022
Current report filing
8-K
Thursday, 8/4/2022
Current report filing
8-K
Monday, 6/27/2022
Current report filing
8-K
Tuesday, 5/10/2022
Current report filing
8-K
Thursday, 3/10/2022
Current report filing
8-K
Wednesday, 3/31/2021
Current report filing
8-K
Tuesday, 3/2/2021
Current report filing
8-K
Monday, 2/22/2021
Current report filing
8-K
Tuesday, 2/16/2021
Current report filing
8-K
Thursday, 2/11/2021
Current report filing
8-K
Tuesday, 12/15/2020
Current report filing
8-K
Tuesday, 10/27/2020
Current report filing
Other (179)
144
Tuesday, 1/16/2024
Filing for proposed sale of securities under Rule 144
144
Friday, 1/12/2024
Filing for proposed sale of securities under Rule 144
144
Friday, 1/5/2024
Filing for proposed sale of securities under Rule 144
EFFECT
Tuesday, 10/10/2023
Notice of Effectiveness
CORRESP
Friday, 10/6/2023
A correspondence can be sent as a document with another submission type or can be sent as a separate submission.
CORRESP
Friday, 10/6/2023
A correspondence can be sent as a document with another submission type or can be sent as a separate submission.
CORRESP
Tuesday, 10/3/2023
A correspondence can be sent as a document with another submission type or can be sent as a separate submission.
EFFECT
Tuesday, 12/29/2020
Notice of Effectiveness
EFFECT
Tuesday, 12/29/2020
Notice of Effectiveness
CORRESP
Wednesday, 12/23/2020
A correspondence can be sent as a document with another submission type or can be sent as a separate submission.
CORRESP
Wednesday, 12/23/2020
A correspondence can be sent as a document with another submission type or can be sent as a separate submission.
CORRESP
Wednesday, 12/23/2020
A correspondence can be sent as a document with another submission type or can be sent as a separate submission.
CORRESP
Wednesday, 12/23/2020
A correspondence can be sent as a document with another submission type or can be sent as a separate submission.
6-K
Monday, 9/21/2020
Current report of foreign issuer pursuant to Rules 13a-16 and 15d-16 Amendments
6-K
Thursday, 9/17/2020
Current report of foreign issuer pursuant to Rules 13a-16 and 15d-16 Amendments
6-K
Monday, 9/14/2020
Current report of foreign issuer pursuant to Rules 13a-16 and 15d-16 Amendments
6-K
Thursday, 9/10/2020
Current report of foreign issuer pursuant to Rules 13a-16 and 15d-16 Amendments
6-K
Friday, 8/7/2020
Current report of foreign issuer pursuant to Rules 13a-16 and 15d-16 Amendments
6-K
Thursday, 8/6/2020
Current report of foreign issuer pursuant to Rules 13a-16 and 15d-16 Amendments
6-K
Friday, 7/31/2020
Current report of foreign issuer pursuant to Rules 13a-16 and 15d-16 Amendments
6-K
Wednesday, 7/29/2020
Current report of foreign issuer pursuant to Rules 13a-16 and 15d-16 Amendments
6-K
Tuesday, 7/28/2020
Current report of foreign issuer pursuant to Rules 13a-16 and 15d-16 Amendments
6-K
Wednesday, 7/15/2020
Current report of foreign issuer pursuant to Rules 13a-16 and 15d-16 Amendments
6-K
Monday, 6/22/2020
Current report of foreign issuer pursuant to Rules 13a-16 and 15d-16 Amendments
6-K
Wednesday, 5/27/2020
Current report of foreign issuer pursuant to Rules 13a-16 and 15d-16 Amendments
6-K
Friday, 5/15/2020
Current report of foreign issuer pursuant to Rules 13a-16 and 15d-16 Amendments
6-K
Thursday, 5/7/2020
Current report of foreign issuer pursuant to Rules 13a-16 and 15d-16 Amendments
6-K
Friday, 5/1/2020
Current report of foreign issuer pursuant to Rules 13a-16 and 15d-16 Amendments
6-K
Wednesday, 4/15/2020
Current report of foreign issuer pursuant to Rules 13a-16 and 15d-16 Amendments
6-K
Tuesday, 4/14/2020
Current report of foreign issuer pursuant to Rules 13a-16 and 15d-16 Amendments
6-K
Tuesday, 4/14/2020
Current report of foreign issuer pursuant to Rules 13a-16 and 15d-16 Amendments
6-K
Tuesday, 3/31/2020
Current report of foreign issuer pursuant to Rules 13a-16 and 15d-16 Amendments
6-K
Friday, 2/28/2020
Current report of foreign issuer pursuant to Rules 13a-16 and 15d-16 Amendments
6-K
Friday, 2/14/2020
Current report of foreign issuer pursuant to Rules 13a-16 and 15d-16 Amendments
6-K
Tuesday, 2/11/2020
Current report of foreign issuer pursuant to Rules 13a-16 and 15d-16 Amendments
20-F
Friday, 12/20/2019
Annual and transition report of foreign private issuers pursuant to Section 13 or 15(d)
6-K
Friday, 12/20/2019
Current report of foreign issuer pursuant to Rules 13a-16 and 15d-16 Amendments
F-3/A
Tuesday, 11/5/2019
Registration statement for specified transactions by certain foreign private issuers
EFFECT
Tuesday, 11/5/2019
Notice of Effectiveness
CORRESP
Friday, 11/1/2019
A correspondence can be sent as a document with another submission type or can be sent as a separate submission.
6-K
Wednesday, 10/30/2019
Current report of foreign issuer pursuant to Rules 13a-16 and 15d-16 Amendments
6-K
Monday, 10/28/2019
Current report of foreign issuer pursuant to Rules 13a-16 and 15d-16 Amendments
6-K
Monday, 10/21/2019
Current report of foreign issuer pursuant to Rules 13a-16 and 15d-16 Amendments
6-K
Friday, 10/18/2019
Current report of foreign issuer pursuant to Rules 13a-16 and 15d-16 Amendments
F-3
Wednesday, 10/9/2019
Registration statement for specified transactions by certain foreign private issuers
6-K
Monday, 10/7/2019
Current report of foreign issuer pursuant to Rules 13a-16 and 15d-16 Amendments
6-K
Monday, 9/30/2019
Current report of foreign issuer pursuant to Rules 13a-16 and 15d-16 Amendments
6-K
Thursday, 9/19/2019
Current report of foreign issuer pursuant to Rules 13a-16 and 15d-16 Amendments
6-K
Thursday, 9/5/2019
Current report of foreign issuer pursuant to Rules 13a-16 and 15d-16 Amendments
D
Friday, 8/30/2019
Exempt (Private) Offering
6-K
Wednesday, 8/28/2019
Current report of foreign issuer pursuant to Rules 13a-16 and 15d-16 Amendments
6-K
Friday, 8/23/2019
Current report of foreign issuer pursuant to Rules 13a-16 and 15d-16 Amendments
6-K
Wednesday, 8/14/2019
Current report of foreign issuer pursuant to Rules 13a-16 and 15d-16 Amendments
6-K
Wednesday, 7/31/2019
Current report of foreign issuer pursuant to Rules 13a-16 and 15d-16 Amendments
6-K
Tuesday, 7/30/2019
Current report of foreign issuer pursuant to Rules 13a-16 and 15d-16 Amendments
6-K
Monday, 7/15/2019
Current report of foreign issuer pursuant to Rules 13a-16 and 15d-16 Amendments
6-K
Monday, 7/8/2019
Current report of foreign issuer pursuant to Rules 13a-16 and 15d-16 Amendments
6-K
Thursday, 6/27/2019
Current report of foreign issuer pursuant to Rules 13a-16 and 15d-16 Amendments
6-K
Wednesday, 6/26/2019
Current report of foreign issuer pursuant to Rules 13a-16 and 15d-16 Amendments
6-K
Monday, 6/24/2019
Current report of foreign issuer pursuant to Rules 13a-16 and 15d-16 Amendments
6-K
Tuesday, 5/28/2019
Current report of foreign issuer pursuant to Rules 13a-16 and 15d-16 Amendments
6-K
Thursday, 5/16/2019
Current report of foreign issuer pursuant to Rules 13a-16 and 15d-16 Amendments
6-K
Friday, 5/10/2019
Current report of foreign issuer pursuant to Rules 13a-16 and 15d-16 Amendments
6-K
Monday, 5/6/2019
Current report of foreign issuer pursuant to Rules 13a-16 and 15d-16 Amendments
6-K
Thursday, 4/25/2019
Current report of foreign issuer pursuant to Rules 13a-16 and 15d-16 Amendments
6-K
Wednesday, 4/17/2019
Current report of foreign issuer pursuant to Rules 13a-16 and 15d-16 Amendments
6-K
Friday, 4/12/2019
Current report of foreign issuer pursuant to Rules 13a-16 and 15d-16 Amendments
6-K
Thursday, 3/28/2019
Current report of foreign issuer pursuant to Rules 13a-16 and 15d-16 Amendments
6-K
Thursday, 3/28/2019
Current report of foreign issuer pursuant to Rules 13a-16 and 15d-16 Amendments
6-K
Monday, 3/18/2019
Current report of foreign issuer pursuant to Rules 13a-16 and 15d-16 Amendments
6-K
Thursday, 3/14/2019
Current report of foreign issuer pursuant to Rules 13a-16 and 15d-16 Amendments
6-K
Tuesday, 2/19/2019
Current report of foreign issuer pursuant to Rules 13a-16 and 15d-16 Amendments
6-K
Monday, 2/11/2019
Current report of foreign issuer pursuant to Rules 13a-16 and 15d-16 Amendments
6-K
Thursday, 2/7/2019
Current report of foreign issuer pursuant to Rules 13a-16 and 15d-16 Amendments
6-K
Thursday, 12/13/2018
Current report of foreign issuer pursuant to Rules 13a-16 and 15d-16 Amendments
20-F
Thursday, 12/13/2018
Annual and transition report of foreign private issuers pursuant to Section 13 or 15(d)
6-K
Tuesday, 11/6/2018
Current report of foreign issuer pursuant to Rules 13a-16 and 15d-16 Amendments
6-K
Monday, 10/22/2018
Current report of foreign issuer pursuant to Rules 13a-16 and 15d-16 Amendments
6-K
Wednesday, 8/29/2018
Current report of foreign issuer pursuant to Rules 13a-16 and 15d-16 Amendments
6-K
Tuesday, 8/14/2018
Current report of foreign issuer pursuant to Rules 13a-16 and 15d-16 Amendments
EFFECT
Tuesday, 7/17/2018
Notice of Effectiveness
F-3/A
Thursday, 7/12/2018
Registration statement for specified transactions by certain foreign private issuers
CORRESP
Thursday, 7/12/2018
A correspondence can be sent as a document with another submission type or can be sent as a separate submission.
F-3
Thursday, 6/28/2018
Registration statement for specified transactions by certain foreign private issuers
6-K
Friday, 5/25/2018
Current report of foreign issuer pursuant to Rules 13a-16 and 15d-16 Amendments
6-K
Tuesday, 5/15/2018
Current report of foreign issuer pursuant to Rules 13a-16 and 15d-16 Amendments
6-K
Friday, 5/11/2018
Current report of foreign issuer pursuant to Rules 13a-16 and 15d-16 Amendments
6-K
Tuesday, 5/8/2018
Current report of foreign issuer pursuant to Rules 13a-16 and 15d-16 Amendments
6-K
Thursday, 4/26/2018
Current report of foreign issuer pursuant to Rules 13a-16 and 15d-16 Amendments
6-K
Wednesday, 4/25/2018
Current report of foreign issuer pursuant to Rules 13a-16 and 15d-16 Amendments
6-K
Tuesday, 4/24/2018
Current report of foreign issuer pursuant to Rules 13a-16 and 15d-16 Amendments
6-K
Friday, 4/20/2018
Current report of foreign issuer pursuant to Rules 13a-16 and 15d-16 Amendments
6-K
Thursday, 3/29/2018
Current report of foreign issuer pursuant to Rules 13a-16 and 15d-16 Amendments
6-K
Tuesday, 3/6/2018
Current report of foreign issuer pursuant to Rules 13a-16 and 15d-16 Amendments
6-K
Friday, 2/23/2018
Current report of foreign issuer pursuant to Rules 13a-16 and 15d-16 Amendments
6-K
Tuesday, 2/13/2018
Current report of foreign issuer pursuant to Rules 13a-16 and 15d-16 Amendments
EFFECT
Friday, 2/2/2018
Notice of Effectiveness
CORRESP
Wednesday, 1/31/2018
A correspondence can be sent as a document with another submission type or can be sent as a separate submission.
6-K
Friday, 1/26/2018
Current report of foreign issuer pursuant to Rules 13a-16 and 15d-16 Amendments
6-K
Friday, 1/26/2018
Current report of foreign issuer pursuant to Rules 13a-16 and 15d-16 Amendments
Ownership (142)
SC 13G
Wednesday, 2/14/2024
RTW INVESTMENTS, LP: Major Shareholders
SC 13G/A
Wednesday, 2/14/2024
PFM Health Sciences, LP: Major Shareholders
SC 13G/A
Tuesday, 2/13/2024
BB BIOTECH AG: Major Shareholders
SC 13G
Thursday, 2/8/2024
MORGAN STANLEY: Major Shareholders
4
Wednesday, 2/7/2024
Virsik Peter: Statement of changes in beneficial ownership of securities
4
Tuesday, 2/6/2024
Virsik Peter: Statement of changes in beneficial ownership of securities
SC 13G/A
Tuesday, 1/23/2024
Soleus Capital, LLC: Major Shareholders
4
Wednesday, 1/17/2024
Virsik Peter: Statement of changes in beneficial ownership of securities
4
Tuesday, 1/16/2024
Requadt Scott: Statement of changes in beneficial ownership of securities
4
Monday, 1/8/2024
Virsik Peter: Statement of changes in beneficial ownership of securities
4
Monday, 12/18/2023
Parkinson David Ross: Statement of changes in beneficial ownership of securities
4
Friday, 11/24/2023
Wood David S.: Statement of changes in beneficial ownership of securities
4
Wednesday, 11/22/2023
BERGER FRANKLIN M: Statement of changes in beneficial ownership of securities
4
Thursday, 11/16/2023
BERGER FRANKLIN M: Statement of changes in beneficial ownership of securities
3
Tuesday, 6/6/2023
Merendino Lauren: Initial statement of beneficial ownership of securities
SC 13G/A
Tuesday, 2/14/2023
EVENTIDE ASSET MANAGEMENT, LLC: Major Shareholders
SC 13G/A
Tuesday, 2/14/2023
PFM Health Sciences, LP: Major Shareholders
SC 13G/A
Tuesday, 2/14/2023
RTW INVESTMENTS, LP: Major Shareholders
SC 13G/A
Tuesday, 2/14/2023
Soleus Capital, LLC: Major Shareholders
SC 13G/A
Tuesday, 2/14/2023
Avidity Partners Management LP: Major Shareholders
SC 13G/A
Tuesday, 2/14/2023
BB BIOTECH AG: Major Shareholders
SC 13G/A
Thursday, 2/9/2023
JANUS HENDERSON GROUP PLC: Major Shareholders
4
Thursday, 1/5/2023
Parkinson David Ross: Statement of changes in beneficial ownership of securities
4
Thursday, 1/5/2023
BERGER FRANKLIN M: Statement of changes in beneficial ownership of securities
4
Thursday, 1/5/2023
Wood David S.: Statement of changes in beneficial ownership of securities
SC 13G
Thursday, 11/10/2022
PFM Health Sciences, LP: Major Shareholders
4
Tuesday, 11/1/2022
Wood David S.: Statement of changes in beneficial ownership of securities
4
Tuesday, 11/1/2022
Cesano Alessandra: Statement of changes in beneficial ownership of securities
4
Tuesday, 11/1/2022
Thorell Marella: Statement of changes in beneficial ownership of securities
4
Tuesday, 11/1/2022
ZWEIFACH SANFORD S: Statement of changes in beneficial ownership of securities
4
Tuesday, 11/1/2022
Glickman Richard M: Statement of changes in beneficial ownership of securities
4
Tuesday, 11/1/2022
Sollis Gary: Statement of changes in beneficial ownership of securities
4
Tuesday, 11/1/2022
Virsik Peter: Statement of changes in beneficial ownership of securities
4
Tuesday, 11/1/2022
Martin John Alexander: Statement of changes in beneficial ownership of securities
4
Tuesday, 11/1/2022
Parkinson David Ross: Statement of changes in beneficial ownership of securities
4
Tuesday, 11/1/2022
Requadt Scott: Statement of changes in beneficial ownership of securities
4
Tuesday, 11/1/2022
BERGER FRANKLIN M: Statement of changes in beneficial ownership of securities
4
Friday, 10/28/2022
BB BIOTECH AG: Statement of changes in beneficial ownership of securities
SC 13G
Thursday, 10/27/2022
Avidity Partners Management LP: Major Shareholders
3
Wednesday, 9/21/2022
Kantoff Philip W.: Initial statement of beneficial ownership of securities
3
Thursday, 7/21/2022
BIOTECHNOLOGY VALUE FUND L P: Initial statement of beneficial ownership of securities
4
Wednesday, 7/20/2022
BB BIOTECH AG: Statement of changes in beneficial ownership of securities
4
Monday, 7/18/2022
BB BIOTECH AG: Statement of changes in beneficial ownership of securities
SC 13G/A
Tuesday, 7/12/2022
BIOTECHNOLOGY VALUE FUND L P: Major Shareholders
4
Tuesday, 7/5/2022
Parkinson David Ross: Statement of changes in beneficial ownership of securities
4
Thursday, 4/28/2022
BB BIOTECH AG: Statement of changes in beneficial ownership of securities
SC 13G/A
Monday, 2/14/2022
RTW INVESTMENTS, LP: Major Shareholders
SC 13G/A
Monday, 2/14/2022
EVENTIDE ASSET MANAGEMENT, LLC: Major Shareholders
SC 13G/A
Monday, 2/14/2022
BIOTECHNOLOGY VALUE FUND L P: Major Shareholders
SC 13G
Friday, 2/11/2022
JANUS HENDERSON GROUP PLC: Major Shareholders
SC 13G/A
Friday, 2/11/2022
PFIZER INC: Major Shareholders
SC 13G/A
Friday, 2/11/2022
Vivo Capital IX, LLC: Major Shareholders
SC 13G/A
Friday, 2/11/2022
BB BIOTECH AG: Major Shareholders
SC 13G/A
Thursday, 2/10/2022
Soleus Capital, LLC: Major Shareholders
SC 13D/A
Wednesday, 1/12/2022
Clarus Lifesciences III, L.P.: Major Shareholders
SC 13G/A
Monday, 8/23/2021
DRIEHAUS CAPITAL MANAGEMENT LLC: Major Shareholders
4
Friday, 8/20/2021
BB BIOTECH AG: Statement of changes in beneficial ownership of securities
3
Tuesday, 8/17/2021
BB BIOTECH AG: Initial statement of beneficial ownership of securities
SC 13G/A
Tuesday, 8/17/2021
BB BIOTECH AG: Major Shareholders
SC 13G
Friday, 7/2/2021
RTW INVESTMENTS, LP: Major Shareholders
SC 13G
Wednesday, 5/5/2021
BB BIOTECH AG: Major Shareholders
4
Thursday, 3/4/2021
BERGER FRANKLIN M: Statement of changes in beneficial ownership of securities
SC 13G
Tuesday, 2/16/2021
DRIEHAUS CAPITAL MANAGEMENT LLC: Major Shareholders
SC 13G
Tuesday, 2/16/2021
DRIEHAUS CAPITAL MANAGEMENT LLC: Major Shareholders
SC 13G/A
Friday, 2/12/2021
EVENTIDE ASSET MANAGEMENT, LLC: Major Shareholders
SC 13G/A
Friday, 2/12/2021
Omega Fund IV, L.P.: Major Shareholders
SC 13G/A
Friday, 2/12/2021
Vivo Capital IX, LLC: Major Shareholders
SC 13G/A
Friday, 2/12/2021
Soleus Capital, LLC: Major Shareholders
SC 13G/A
Thursday, 2/11/2021
BIOTECHNOLOGY VALUE FUND L P: Major Shareholders
4/A
Tuesday, 1/26/2021
BERGER FRANKLIN M: Statement of changes in beneficial ownership of securities
4/A
Tuesday, 1/26/2021
Glickman Richard M: Statement of changes in beneficial ownership of securities
4/A
Tuesday, 1/26/2021
Sollis Gary: Statement of changes in beneficial ownership of securities
4/A
Tuesday, 1/26/2021
Martin John Alexander: Statement of changes in beneficial ownership of securities
4/A
Tuesday, 1/26/2021
Thorell Marella: Statement of changes in beneficial ownership of securities
4/A
Tuesday, 1/26/2021
ZWEIFACH SANFORD S: Statement of changes in beneficial ownership of securities
4/A
Tuesday, 1/26/2021
Brettman Ari David: Statement of changes in beneficial ownership of securities
4/A
Tuesday, 1/26/2021
Requadt Scott: Statement of changes in beneficial ownership of securities
4
Monday, 1/11/2021
Martin John Alexander: Statement of changes in beneficial ownership of securities
4
Monday, 1/11/2021
Brettman Ari David: Statement of changes in beneficial ownership of securities
4
Monday, 1/11/2021
Requadt Scott: Statement of changes in beneficial ownership of securities
4
Monday, 1/11/2021
Glickman Richard M: Statement of changes in beneficial ownership of securities
4
Monday, 1/11/2021
Parkinson David Ross: Statement of changes in beneficial ownership of securities
4
Monday, 1/11/2021
Virsik Peter: Statement of changes in beneficial ownership of securities
4
Monday, 1/11/2021
Thorell Marella: Statement of changes in beneficial ownership of securities
4
Monday, 1/11/2021
ZWEIFACH SANFORD S: Statement of changes in beneficial ownership of securities
4
Monday, 1/11/2021
Sollis Gary: Statement of changes in beneficial ownership of securities
4
Monday, 1/11/2021
Wood David S.: Statement of changes in beneficial ownership of securities
4
Monday, 1/11/2021
BERGER FRANKLIN M: Statement of changes in beneficial ownership of securities
4
Monday, 1/11/2021
Cesano Alessandra: Statement of changes in beneficial ownership of securities
SC 13G
Friday, 11/6/2020
Vivo Capital IX, LLC: Major Shareholders
3
Friday, 10/2/2020
ZWEIFACH SANFORD S: Initial statement of beneficial ownership of securities
3
Friday, 10/2/2020
Martin John Alexander: Initial statement of beneficial ownership of securities
3
Thursday, 10/1/2020
Brettman Ari David: Initial statement of beneficial ownership of securities
3
Thursday, 10/1/2020
Parkinson David Ross: Initial statement of beneficial ownership of securities
3
Thursday, 10/1/2020
Requadt Scott: Initial statement of beneficial ownership of securities
3
Thursday, 10/1/2020
BERGER FRANKLIN M: Initial statement of beneficial ownership of securities
3
Thursday, 10/1/2020
Glickman Richard M: Initial statement of beneficial ownership of securities
3
Thursday, 10/1/2020
Wood David S.: Initial statement of beneficial ownership of securities
3
Thursday, 10/1/2020
Sollis Gary: Initial statement of beneficial ownership of securities
3
Thursday, 10/1/2020
Cesano Alessandra: Initial statement of beneficial ownership of securities
Prospectus (24)
424B5
Monday, 11/6/2023
Prospectus filed pursuant to Rule 424(b)(5)
S-3/A
Tuesday, 10/3/2023
Registration statement for specified transactions by certain issuers
S-3
Tuesday, 9/19/2023
Registration statement for specified transactions by certain issuers
S-8
Friday, 10/1/2021
Initial registration statement for securities to be offered to employees pursuant to employee benefit plans
S-3ASR
Monday, 6/21/2021
Automatic shelf registration statement of securities of well-known seasoned issuers
424B5
Thursday, 2/18/2021
Prospectus filed pursuant to Rule 424(b)(5)
424B5
Tuesday, 2/16/2021
Prospectus filed pursuant to Rule 424(b)(5)
S-3/A
Wednesday, 12/23/2020
Registration statement for specified transactions by certain issuers
S-3/A
Wednesday, 12/23/2020
Registration statement for specified transactions by certain issuers
S-3
Wednesday, 11/25/2020
Registration statement for specified transactions by certain issuers
S-3
Wednesday, 11/25/2020
Registration statement for specified transactions by certain issuers
S-8
Thursday, 8/13/2020
Initial registration statement for securities to be offered to employees pursuant to employee benefit plans
424B5
Thursday, 7/30/2020
Prospectus filed pursuant to Rule 424(b)(5)
424B5
Tuesday, 7/28/2020
Prospectus filed pursuant to Rule 424(b)(5)
S-8
Monday, 6/29/2020
Initial registration statement for securities to be offered to employees pursuant to employee benefit plans
424B5
Monday, 4/13/2020
Prospectus filed pursuant to Rule 424(b)(5)
S-8
Friday, 5/18/2018
Initial registration statement for securities to be offered to employees pursuant to employee benefit plans
S-8 POS
Friday, 5/18/2018
Post-effective amendment to a S-8 registration statement
S-8
Tuesday, 3/15/2016
Initial registration statement for securities to be offered to employees pursuant to employee benefit plans
DRS/A
Friday, 5/8/2015
Draft registration statement submitted by Emerging Growth Company under Securities Act Section 6(e) or by Foreign Private Issuer under Division of Corporation Finance policy
DRSLTR
Friday, 5/8/2015
Correspondence Related to Draft Registration Statement
DRS/A
Tuesday, 4/7/2015
Draft registration statement submitted by Emerging Growth Company under Securities Act Section 6(e) or by Foreign Private Issuer under Division of Corporation Finance policy
DRSLTR
Tuesday, 4/7/2015
Correspondence Related to Draft Registration Statement
DRS
Tuesday, 2/24/2015
Draft registration statement submitted by Emerging Growth Company under Securities Act Section 6(e) or by Foreign Private Issuer under Division of Corporation Finance policy
Proxies (6)
DEFA14A
Friday, 1/26/2024
Definitive additional proxy soliciting materials including Rule 14(a)(12) material. Note: Submission type DEFA14A can be filed as part of Form 8-K. For filers subject to 8-K filing requirements, we recommend the use of the 8-K combined form type as the easiest method for fulfilling your filing requirement for both forms.
DEF 14A
Friday, 1/26/2024
Definitive proxy statements
DEF 14A
Tuesday, 1/24/2023
Definitive proxy statements
DEF 14A
Friday, 1/28/2022
Definitive proxy statements
DEF 14A
Tuesday, 1/26/2021
Definitive proxy statements
PRE 14A
Tuesday, 1/19/2021
Preliminary proxy statement not related to a contested matter or merger/acquisition